An intelligent grading system based on deep learning algorithms that assists doctors and researchers in analyzing liver biopsy samples and checking liver fibrosis grades using unified data standards. The system converts traditional qualitative grading to quantitative grading, improving grading accur...
Manufactured by
Hangzhou Precision MedCare co.LTD
China
Hangzhou Precision MedCare is a digital healthcare company founded in 2019, specializing in AI and cloud computing applications for medical services. The company has developed proprietary thyroid and breast screening technology that has served over 2 million residents across 105 communities in China. It holds 2 Class II medical device registration certificates, 6 invention patents, and is recognized as a national technology-based SME.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SHENZHEN ANQUN BIOTECH CO.,LTD.
China · 2 relevant products
Echosens China
China · 1 relevant product
Mediwhale Inc.
South Korea · 3 relevant products
7 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 6 relevant matches
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
A diagnostic test series for the detection and assessment of liver fibrosis in patients.
Beijing O&D Biotech Co., Ltd. · China
Chemiluminescence-based assay for detection of liver fibrosis biomarkers. Supports non-invasive assessment of hepatic fibrosis and liver disease progression. Multiple regulatory approvals across domestic and international markets.
Echosens China · China
A solution that enhances FibroScan liver disease assessment by combining FibroScan measurements with biological markers to provide improved diagnostic and prognostic information for patients with liver disease. Available variants: FibroScan®-based Scores.
3 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products